ARL Bio Pharma

ARL Bio Pharma

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

ARL Bio Pharma is a privately-held, revenue-generating contract research organization (CRO) specializing in pharmaceutical testing services. Based in Oklahoma City, the company serves a diverse client base including compounding pharmacies, raw material suppliers, and biopharma companies with services essential for regulatory compliance (e.g., USP/EP/JP, NDA/ANDA support) and product quality assurance. Its business model is built on providing essential, outsourced laboratory testing, with expertise spanning analytical chemistry, microbiology, stability studies, and forensic analysis. The company's value proposition centers on reliability, regulatory expertise, and acting as an extension of its clients' quality control departments.

DiagnosticsDrug Delivery

Technology Platform

Accredited analytical and microbiological testing laboratory utilizing pharmacopeial methods (USP, EP, JP) including HPLC, UV, sterility, endotoxin, and particulate matter analysis for pharmaceutical quality control and regulatory compliance.

Opportunities

Growth is driven by increased outsourcing of QC by pharma companies, stringent regulation of compounding pharmacies, and the need for testing against global pharmacopeial standards.
Expansion into new service areas like advanced therapy medicinal products (ATMPs) testing presents further opportunity.

Risk Factors

Key risks include intense competition from other CROs, regulatory risk associated with maintaining lab accreditations, potential client concentration, and vulnerability to downturns in pharmaceutical R&D or manufacturing spending.

Competitive Landscape

ARL competes in a fragmented market with other specialized testing labs and large, global CROs that offer analytical services. Its niche focus on pharmaceutical and compounding pharmacy testing differentiates it from broader environmental or clinical trial labs, but it faces direct competition on price, turnaround time, and technical expertise.